S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
BREAKING: Tiny biotech successfully treats blindness (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: Tiny biotech successfully treats blindness (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
BREAKING: Tiny biotech successfully treats blindness (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: Tiny biotech successfully treats blindness (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
BREAKING: Tiny biotech successfully treats blindness (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: Tiny biotech successfully treats blindness (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
BREAKING: Tiny biotech successfully treats blindness (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: Tiny biotech successfully treats blindness (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
NYSE:ABT

Abbott Laboratories (ABT) SEC Filings & 10K Form

$96.85
-1.27 (-1.29%)
(As of 09/29/2023 08:52 PM ET)
Compare
Today's Range
$96.48
$98.51
50-Day Range
$95.55
$114.62
52-Week Range
$93.25
$115.83
Volume
5.15 million shs
Average Volume
4.89 million shs
Market Capitalization
$168.07 billion
P/E Ratio
33.05
Dividend Yield
2.11%
Price Target
$120.82

Recent Abbott Laboratories SEC Filings

DateFilerForm TypeView
09/15/2023
4:35 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
5:48 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2023
5:50 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
5:53 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:13 PM
Abbott Laboratories (Filer)
Form 8-K/A
08/10/2023
5:31 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
4:10 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
7:29 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
10:54 AM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
10:55 AM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
10:56 AM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
10:57 AM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
10:57 AM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:07 PM
Abbott Laboratories (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/20/2023
5:55 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
2:18 PM
Abbott Laboratories (Subject)
Boudreau Philip P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2023
9:32 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2023
6:09 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
5:13 AM
Abbott Laboratories (Filer)
Form S-3ASR
05/02/2023
6:57 PM
Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:59 PM
Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
7:02 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
7:04 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
7:08 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:51 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:53 PM
Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:55 PM
Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:33 PM
Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/02/2023
6:34 PM
Abbott Laboratories (Subject)
MANNING JOSEPH J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2023
6:37 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:39 PM
Abbott Laboratories (Issuer)
Babineaux-Fontenot Claire (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:42 PM
Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:01 PM
Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2023
6:26 PM
Abbott Laboratories (Subject)
WOODGRIFT RANDEL WILLIAM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2023
2:25 PM
Abbott Laboratories (Subject)
STARKS DANIEL J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2023
5:00 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2023
6:25 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2023
10:53 AM
Abbott Laboratories (Subject)
Canadian Shareholder Association for Research & Education (Filed by)
Form PX14A6G
04/04/2023
6:25 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
6:27 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
6:29 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2023
6:32 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:43 PM
Abbott Laboratories (Issuer)
Mateus Fernando (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:45 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:47 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:49 PM
Abbott Laboratories (Issuer)
PEDERSON MICHAEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:52 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:55 PM
Abbott Laboratories (Issuer)
Tyler Julie L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:27 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:30 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:35 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:36 PM
Abbott Laboratories (Issuer)
Ginascol John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:38 PM
Abbott Laboratories (Issuer)
Karam Sammy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:40 PM
Abbott Laboratories (Issuer)
MANNING JOSEPH J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:16 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:19 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:22 PM
Abbott Laboratories (Issuer)
Calamari Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:23 PM
Abbott Laboratories (Issuer)
CAPEK JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:25 PM
Abbott Laboratories (Issuer)
DALE MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2023
6:13 PM
Abbott Laboratories (Issuer)
Ahlberg Gregory A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:29 PM
Abbott Laboratories (Issuer)
WOODGRIFT RANDEL WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:58 PM
Abbott Laboratories (Issuer)
Karam Sammy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:00 PM
Abbott Laboratories (Issuer)
MANNING JOSEPH J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:03 PM
Abbott Laboratories (Issuer)
Mateus Fernando (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:14 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:16 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:18 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:20 PM
Abbott Laboratories (Issuer)
Tyler Julie L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:22 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:24 PM
Abbott Laboratories (Issuer)
Watkin Jared (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
6:25 PM
Abbott Laboratories (Issuer)
Wellisch Alejandro D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:48 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:50 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:53 PM
Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:56 PM
Abbott Laboratories (Issuer)
Ginascol John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:37 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:38 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:40 PM
Abbott Laboratories (Issuer)
Calamari Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:43 PM
Abbott Laboratories (Issuer)
CAPEK JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:46 PM
Abbott Laboratories (Issuer)
DALE MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
5:34 PM
Abbott Laboratories (Issuer)
Ahlberg Gregory A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2023
9:54 AM
Abbott Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/06/2023
3:35 PM
Abbott Laboratories (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/25/2023
6:38 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2023
5:13 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2023
5:15 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2023
5:17 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2023
5:09 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2023
4:32 PM
Abbott Laboratories (Issuer)
Karam Sammy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2022
4:26 PM
Abbott Laboratories (Issuer)
Ginascol John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2022
3:06 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2022
4:44 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2022
3:05 PM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2022
6:58 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2022
4:24 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
4:26 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
4:27 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
4:30 PM
Abbott Laboratories (Issuer)
Ahlberg Gregory A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:ABT) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -